Standout Papers

FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Ca... 2022 2026 2023 2024113
  1. FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer (2022)
    Jaleh Fallah, Sundeep Agrawal et al. Clinical Cancer Research

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 55 standout
Sub-graph 1 of 24

Citing Papers

In-situ-sprayed therapeutic hydrogel for oxygen-actuated Janus regulation of postsurgical tumor recurrence/metastasis and wound healing
2024 Standout
Targeting the Warburg Effect in Cancer: Where Do We Stand?
2024 Standout
2 intermediate papers

Works of Jaleh Fallah being referenced

HIF Inhibitors: Status of Current Clinical Development
2019

Author Peers

Author Last Decade Papers Cites
Jaleh Fallah 186 199 212 198 25 564
Marie‐Christine Baranzelli 183 213 165 144 32 522
Parvin F. Peddi 192 392 148 200 28 635
E Leonardo 239 255 88 200 20 619
Emily Tarco 110 342 148 324 19 608
Christine Khoo 137 222 144 215 21 528
Zhenxiong Wang 189 180 78 234 24 539
Karen Drumea 140 129 170 139 36 592
Matteo Clavarezza 133 399 157 108 46 616
Petros M. Pavlopoulos 116 125 154 317 28 638
Lucia Trandafir 269 247 85 280 22 629

All Works

Loading papers...

Rankless by CCL
2026